卑诗省列治文，2018年5月28日 – Eastwood Bio-medical Canada Inc. (TSXV: EBM)（下称”本公司”）欣然宣布近期实现了多个重要里程碑，成功扩建生产设施和推出新产品。
Eastwood Bio-medical Canada Inc.是一家生物技术公司，致力于研究和商业化治疗糖尿病、肥胖症、高血压和痴呆症等血糖相关疾病的生物技术，也在进军天然保健品生产业务。
本公司的股价在2018年4月低至$0.065，但2018年5月28日收于$0.215。总裁兼首席执行官Yunji Kim表示：公司管理层并不知悉公司有任何新的重要运营信息，能对股价大幅上涨的原因作出相应解释。
但是本公司此前宣布，本公司成功扩建了生产设施，并在获得加拿大卫生部营销许可批准之后，推出了新产品。加拿大卫生部是与美国食品药品监督管理局（FDA）权利同等的加拿大政府机构。如前所述，新设施符合GMP标准并获得了加拿大卫生部颁发的许可证，目前每天可生产300万粒胶囊和10,000瓶包装产品。本公司预计该设施每年可节省高达$700万的生产成本。
Kim女士称：”积极扩张生产工厂规模与我们长期以来建立强大企业基础一脉相承。我们的Eleotin®品牌最初以卡尔加里大学Julia Macfarlane糖尿病中心的尖端研究技术为基础。国际大学和糖尿病协会研究并认可了Eleotin®。加拿大广告标准委员会(ASC)已经准许本公司的Eleotin®品牌在加拿大用‘全球最好的’医生推荐天然健康血糖促进产品进行市场推广。”
Kim女士还表示：”我们对公司的扩张感到自豪和兴奋。质量控制一直是我们的优先任务之一。我们首先确保自身具备世界一流的内部生产能力，采用最‘精准’的制造技术，保证生产出最优质的产品，然后以上述前提为基础，我们才会想要挖掘产品的全部市场潜力。”
本公司本月还宣布，在获得加拿大卫生部批准后，上市35款新产品。过去本公司已经持续、快速地引进了科学研发的独特健康解决方案，预计未来将继续增加新产品。
Kim女士表示：”这对我们来说是一个激动人心的时刻。我们为我们所生产的产品感到自豪，并且期待着在未来几个月内不断发展。”
欲了解更多信息，请联系：
Eastwood Bio-medical Canada Inc.
总裁兼首席执行官Yunji Kim
电话: (604)-247-2100
Forward-Looking Statement:
This email contains forward-looking statements and forward-looking information within the meaning of applicable securities laws. The use of any of the words “expect”, “anticipate”, “continue”, “estimate”, “objective”, “ongoing”, “may”, “will”, “project”, “should”, “believe”, “plans”, “intends” and similar expressions are intended to identify forward-looking information or statements. The forward-looking statements and information are based on certain key expectations and assumptions made by the Company, including expectations and assumptions concerning TSXV approvals. Although the Company believes that the expectations and assumptions on which such forward-looking statements and information are based are reasonable, undue reliance should not be placed on the forward-looking statements and information because the Company can give no assurance that they will prove to be correct.
Since forward-looking statements and information address future events and conditions, by their very nature they involve inherent risks and uncertainties. Actual results could differ materially from those currently anticipated due to a number of factors and risks. Certain factors, which could materially affect such forward-looking information are described in the risk factors in the Company’s most recent annual management’s discussion and analysis that is available on the Company’s profile on SEDAR at www.sedar.com. Readers are cautioned that the foregoing list of factors is not exhaustive. The forward-looking statements included in this news release are expressly qualified by this cautionary statement. The forward-looking statements and information contained in this news release are made as of the date hereof and the Company undertakes no obligation to update publicly or revise any forward-looking statements or information, whether as a result of new information, future events or otherwise, unless so required by applicable securities laws.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
免责声明：此文章为NAI Interactive Ltd. 北美投资讯息有限公司有偿发布，本文章内容是为了提供信息，并不构成任何管辖范围下的证券发售或投资建议。本文章的任何内容均不应被解释为要约、推销或推荐购买或销售产品或证券。
